EBGLYSS®(lebrikizumab-lbkz): What could less mean for your patients?

Loading Events

« All Events

EBGLYSS®(lebrikizumab-lbkz): What could less mean for your patients?

June 24 @ 7:00 pm - 8:00 pm

Speaker: Sam Awan, MD, FAAD Board-certified Dermatologist U.S. Dermatology Partners McKinney, Texas Baylor Scott & White Health Southwestern Health Resources

Moderator: Leon Kircik, MD, FAAD Medical Director, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai, New York, NY Indiana University Medical Center, Indianapolis, IN Medical Director Physicians Skin Care, PLLC, Louisville, KY DermResearch, PLLC, Louisville, KY Skin Sciences, PLLC, Louisville, KY

Please join us for our next IDF Educational Series Webinar: EBGLYSS®(lebrikizumab-lbkz): What could less mean for your patients? Join your colleagues for a peer discussion exploring the latest EBGLYSS data. This program is sponsored by, and the speaker is presenting on behalf of, Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit. Please see Prescribing Information and Patient Information at the product theater or on https://ebglyss.lilly.com. Please see Instructions for Use included with the device. EBGLYSS® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

 

REGISTER

Details